Transverse Medical Appoints David K. Stone as Independent Member Director of the Board

Transverse Medical, Inc., developer of the POINT-GUARD™ Dynamic Cerebral Embolic Protection (CEP) device to protect the patient from stroke during Transcatheter Aortic Valve Replacement (TAVR), is pleased to announce the appointment of experienced life sciences professional, board director, former chief financial executive, and consultant, Mr. David K. Stone, as non-executive independent Director member of the Board.(PRWeb February 19, 2020)Read the full story at https://www.prweb.com/releases/transverse_medical_appoints_david_k_stone_as_independent_member_director_of_the_board/prweb16916576.htm

This post was originally published on this site
Advertisement

Transverse Medical, Inc., developer of the POINT-GUARD™ Dynamic Cerebral Embolic Protection (CEP) device to protect the patient from stroke during Transcatheter Aortic Valve Replacement (TAVR), is pleased to announce the appointment of

Advertisement
experienced life sciences professional, board director, former chief financial
Advertisement
executive, and consultant, Mr. David K. Stone, as non-executive independent Director member of the Board.

(PRWeb February 19, 2020)

Read the full story at https://www.prweb.com/releases/transverse_medical_appoints_david_k_stone_as_independent_member_director_of_the_board/prweb16916576.htm